EMX2 is epigenetically silenced and suppresses epithelial‑mesenchymal transition in human esophageal adenocarcinoma

Esophageal adenocarcinoma (EAC) is an aggressive and challenging disease to treat, with an overall five‑year survival rate of

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Oncology reports 2019-11, Vol.42 (5), p.2169-2178
Hauptverfasser:	Wang, Lei, Jin, Joy, Zhou, Yong, Tian, Ziqiang, He, Biao, Huang, Yueyan, Ding, Feng
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma Adenocarcinoma - genetics Aged Analysis Cancer metastasis Cancer research Carcinoma Cell cycle Cell Line, Tumor Chemotherapy Cisplatin - pharmacology Colorectal cancer DNA DNA Methylation Down-Regulation Epigenesis, Genetic Epigenetics Epithelial-Mesenchymal Transition Esophageal cancer Esophageal Neoplasms - genetics Female Gene Expression Regulation, Neoplastic Homeodomain Proteins - genetics Humans Immunoglobulins Male Medical prognosis Metastasis Middle Aged Prognosis Promoter Regions, Genetic Proteins Scientific equipment industry Signal Transduction Stem cells Studies Transcription Factors - genetics Transferases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Esophageal adenocarcinoma (EAC) is an aggressive and challenging disease to treat, with an overall five‑year survival rate of
ISSN:	1021-335X 1791-2431
DOI:	10.3892/or.2019.7284